TP53 and hepatocellular carcinoma: In this study, comparable IL-24-induced anti-tumor activity in vitro was observed in the three HCC cell lines, of which, the cell line HepG2 expresses wild-type p53 but has a mutant Rb, whereas the cell lines SMMC-7721 and Hep3B have mutant p53 [29].